Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Faron Pharmaceuticals (FARN) Share News

Faron Pharmaceuticals annual loss widens on higher research costs

3rd Mar 2023 11:53

(Alliance News) - Faron Pharmaceuticals Ltd on Friday reported a widened loss in 2022 as it ramped up its research & development efforts. Read More

UK earnings, trading statements calendar - next 7 days

24th Feb 2023 15:49

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

27th Jan 2023 18:56

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Faron Pharmaceuticals raises EUR12 million via shares

27th Jan 2023 10:28

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical drug discovery and development company - Raises EUR12.0 million via placing of 3.7 million shares at the issue price of EUR3.25 each. Faron says that with these proceeds and the current level of activity, it has sufficient working capital into the third quarter of 2023. Read More

AIM WINNERS & LOSERS: Faron Pharmaceuticals raises EUR12 million

27th Jan 2023 10:11

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

TRADING UPDATES: Tungsten West 'largest Western tungsten producer'

16th Jan 2023 16:26

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Faron Pharmaceuticals sees patient remission in immunotherapy trials

5th Dec 2022 12:06

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it was encouraged by promising early data from trials for its investigative precision immunotherapy, which aims to provide permanent immune stimulation for difficult-to-treat cancers by targeting myeloid cell function. Read More

TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP

1st Dec 2022 21:42

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Joules nomad resigns; Pharma C loss narrows

18th Nov 2022 19:49

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: 4Global wins deal; James Cropper profit warning

31st Oct 2022 19:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Faron Pharmaceuticals shares down as raises EUR8.4 million in placing

14th Oct 2022 11:14

(Alliance News) - Faron Pharmaceuticals Ltd shares declined on Friday, after it said it has raised EUR8.4 million from a share placing. Read More

TRADING UPDATES: Bidstack names new COO; Fintel expands deal

13th Oct 2022 21:17

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

REPEAT: Faron Pharma half-year loss widens on higher R&D spending

25th Aug 2022 12:10

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said its interim loss widened, as the company reported higher research and administrative expenses and remained revenue-less. Read More

Faron Pharmaceuticals half-year loss widens on higher R&D spending

25th Aug 2022 11:43

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said its interim loss widen, as the company reported higher research and administrative expenses and remained revenue-less. Read More

UK earnings, trading statements calendar - next 7 days

18th Aug 2022 16:02

UK shareholder meetings calendar - next 7 days

30th Jun 2022 15:59

IN BRIEF: Faron raises EUR5 million for bexmarilimab development

28th Jun 2022 18:03

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Conducts private placing to raise EUR5 million in 2.0 million newly issued treasury shares at EUR2.49 each. Once the funds are received, Faron expects to have sufficient working capital to last until the first quarter of 2023. Net proceeds will be largely used for the acceleration of the clinical development program and manufacturing of bexmarilimab, its immunotherapy asset. Read More

IN BRIEF: Faron Pharma reveals topline results from MATINS trial

15th Jun 2022 19:24

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Announces top-line overall survival results from its phase 1/2 'Macrophage Antibody To Inhibit Immune Suppression study, which investigated the safety and efficacy of bexmarilimab monotherapy in ten different hard-to-treat or on operable solid tumour cohorts. Read More

IN BRIEF: Faron Pharma doses first patient in bexmarilimab study

8th Jun 2022 16:54

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Doses first patient in the phase I/II BEXMAB study. The study is investigating bexmarilimab, Faron's wholly-owned precision immunotherapy asset, in combination with azacitidine in multiple hematological malignancies. This marks the first time bexmarilimab is being assessed as part of a clinical study in hematologic malignancies, Faron explains. Read More

IN BRIEF: US and Finland approve Faron's bexmarilimab study

16th May 2022 17:35

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - US Food & Drug Administration and Finnish Medicines Agency clear company's investigational new drug application to start its BEXMAB study, which is for assessing the safety, tolerability and efficacy of precision cancer immunotherapy known as bexmarilimab. Read More

FTSE 100 Latest

Value9,491.25

Change63.52